SPATA2 restricts OTULIN-dependent LUBAC activity independently of CYLD
Laura Griewahn,
Madeleine Müller,
Lukas Peintner,
Manuela Wissler,
Martina Weiss,
Prisca Brauns-Schubert,
Ramin Massoumi,
Christoph Borner,
Olaf Groß,
Monica Yabal,
Céline Charvet,
Ulrich Maurer
Affiliations
Laura Griewahn
Institute of Molecular Medicine and Cell Research, Faculty of Medicine, Albert-Ludwigs-University of Freiburg, 79104 Freiburg, Germany; Spemann Graduate School of Biology and Medicine (SGBM), Albert-Ludwigs-University of Freiburg, 79104 Freiburg, Germany; University of Freiburg, Faculty of Biology, 79104 Freiburg, Germany
Madeleine Müller
Institute of Molecular Immunology and Experimental Oncology, TUM School of Medicine, Technical University of Munich, 81675 Munich, Germany
Lukas Peintner
Institute of Molecular Medicine and Cell Research, Faculty of Medicine, Albert-Ludwigs-University of Freiburg, 79104 Freiburg, Germany
Manuela Wissler
Institute of Molecular Medicine and Cell Research, Faculty of Medicine, Albert-Ludwigs-University of Freiburg, 79104 Freiburg, Germany
Martina Weiss
Institute of Molecular Medicine and Cell Research, Faculty of Medicine, Albert-Ludwigs-University of Freiburg, 79104 Freiburg, Germany
Prisca Brauns-Schubert
Institute of Molecular Medicine and Cell Research, Faculty of Medicine, Albert-Ludwigs-University of Freiburg, 79104 Freiburg, Germany
Ramin Massoumi
Molecular Tumor Pathology, Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, 223 81 Lund, Sweden
Christoph Borner
Institute of Molecular Medicine and Cell Research, Faculty of Medicine, Albert-Ludwigs-University of Freiburg, 79104 Freiburg, Germany; Spemann Graduate School of Biology and Medicine (SGBM), Albert-Ludwigs-University of Freiburg, 79104 Freiburg, Germany; BIOSS, Centre for Biological Signaling Studies, 79104 Freiburg, Germany
Olaf Groß
Institute of Neuropathology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany; CIBSS - Centre for Integrative Biological Signalling Studies, University of Freiburg, 79104 Freiburg, Germany
Monica Yabal
Institute of Molecular Immunology and Experimental Oncology, TUM School of Medicine, Technical University of Munich, 81675 Munich, Germany
Céline Charvet
Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), 67404 Illkirch, France; Centre National de la Recherche Scientifique (CNRS), UMR7104, 67404 Illkirch, France; Institut National de la Santé et de la Recherche Médicale (INSERM), U1258, 67404 Illkirch, France; Université de Strasbourg, 67000 Strasbourg, France
Ulrich Maurer
Institute of Molecular Medicine and Cell Research, Faculty of Medicine, Albert-Ludwigs-University of Freiburg, 79104 Freiburg, Germany; Spemann Graduate School of Biology and Medicine (SGBM), Albert-Ludwigs-University of Freiburg, 79104 Freiburg, Germany; BIOSS, Centre for Biological Signaling Studies, 79104 Freiburg, Germany; Corresponding author
Summary: SPATA2 mediates the recruitment of CYLD to immune receptor complexes by bridging the interaction of CYLD with the linear ubiquitylation assembly complex (LUBAC) component HOIP. Whether SPATA2 exhibits functions independently of CYLD is unclear. Here, we show that, while Cyld−/− and Spata2−/− mice are viable, double mutants exhibit highly penetrant perinatal lethality, indicating independent functions of SPATA2 and CYLD. Cyld−/−Spata2−/− fibroblasts show increased M1-linked TNFR1-SC ubiquitylation and, similar to Cyld−/−Spata2−/− macrophages and intestinal epithelial cells, elevated pro-inflammatory gene expression compared with Cyld−/− or Spata2−/− cells. We show that SPATA2 competes with OTULIN for binding to HOIP via its PUB-interacting motif (PIM) and its zinc finger domain, thereby promoting autoubiquitylation of LUBAC. Consistently, increased pro-inflammatory signaling in Cyld−/−Spata2−/− cells depends on the presence of OTULIN. Our data therefore indicate that SPATA2 counteracts, independently of CYLD, the deubiquitylation of LUBAC by OTULIN and thereby attenuates LUBAC activity and pro-inflammatory signaling.